NeuroBo Pharmaceuticals Long Term Debt 1970-1969 | MTVA
NeuroBo Pharmaceuticals long term debt from 1970 to 1969. Long term debt can be defined as the sum of all long term debt fields.
NeuroBo Pharmaceuticals Annual Long Term Debt
(Millions of US $) |
NeuroBo Pharmaceuticals Quarterly Long Term Debt
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
